BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Johnson and Johnson
Merck
QuintilesIMS
Fuji
Argus Health
UBS
Harvard Business School
Express Scripts
McKesson

Generated: January 23, 2018

DrugPatentWatch Database Preview

PROLIXIN Drug Profile

« Back to Dashboard

When do Prolixin patents expire, and what generic alternatives are available?

Prolixin is a drug marketed by Apothecon and Bristol Myers Squibb and is included in five NDAs.

The generic ingredient in PROLIXIN is fluphenazine enanthate. There are eighteen drug master file entries for this compound. Additional details are available on the fluphenazine enanthate profile page.

US Patents and Regulatory Information for PROLIXIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon PROLIXIN fluphenazine hydrochloride CONCENTRATE;ORAL 070533-001 Nov 7, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apothecon PROLIXIN fluphenazine hydrochloride TABLET;ORAL 011751-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apothecon PROLIXIN fluphenazine hydrochloride TABLET;ORAL 011751-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb PROLIXIN DECANOATE fluphenazine decanoate INJECTABLE;INJECTION 016727-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apothecon PROLIXIN fluphenazine hydrochloride ELIXIR;ORAL 012145-003 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apothecon PROLIXIN fluphenazine hydrochloride INJECTABLE;INJECTION 011751-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apothecon PROLIXIN fluphenazine hydrochloride TABLET;ORAL 011751-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apothecon PROLIXIN fluphenazine hydrochloride TABLET;ORAL 011751-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apothecon PROLIXIN ENANTHATE fluphenazine enanthate INJECTABLE;INJECTION 016110-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cipla
US Department of Justice
Colorcon
UBS
Covington
US Army
Mallinckrodt
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot